211 related articles for article (PubMed ID: 19250763)
1. Testosterone production is better preserved after 16 than 20 Gray irradiation treatment against testicular carcinoma in situ cells.
Bang AK; Petersen JH; Petersen PM; Andersson AM; Daugaard G; Jørgensen N
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):672-6. PubMed ID: 19250763
[TBL] [Abstract][Full Text] [Related]
2. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis.
Petersen PM; Giwercman A; Daugaard G; Rørth M; Petersen JH; Skakkeaek NE; Hansen SW; von der Maase H
J Clin Oncol; 2002 Mar; 20(6):1537-43. PubMed ID: 11896102
[TBL] [Abstract][Full Text] [Related]
3. Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer.
Yau I; Vuong T; Garant A; Ducruet T; Doran P; Faria S; Liberman S; Richard C; Letellier F; Charlebois P; Loungnarath R; Stein B; Devic S
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1481-6. PubMed ID: 19147304
[TBL] [Abstract][Full Text] [Related]
4. Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients.
Giwercman A; von der Maase H; Berthelsen JG; Rørth M; Bertelsen A; Skakkebaek NE
J Clin Endocrinol Metab; 1991 Sep; 73(3):596-603. PubMed ID: 1908483
[TBL] [Abstract][Full Text] [Related]
5. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
Tomić R
Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
[TBL] [Abstract][Full Text] [Related]
6. Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Rørth M; Giwercman A
J Urol; 1999 Mar; 161(3):822-6. PubMed ID: 10022693
[TBL] [Abstract][Full Text] [Related]
7. Alterations in hormone levels after adjuvant chemoradiation in male rectal cancer patients.
Yoon FH; Perera F; Fisher B; Stitt L
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1186-90. PubMed ID: 19095371
[TBL] [Abstract][Full Text] [Related]
8. Testicular dose and hormonal changes after radiotherapy of rectal cancer.
Hermann RM; Henkel K; Christiansen H; Vorwerk H; Hille A; Hess CF; Schmidberger H
Radiother Oncol; 2005 Apr; 75(1):83-8. PubMed ID: 15878105
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy of testicular intraepithelial neoplasia (TIN): a novel treatment regimen for a rare disease.
Sedlmayer F; Höltl W; Kozak W; Hawliczek R; Gebhart F; Gerber E; Joos H; Albrecht W; Pummer K; Kogelnik HD;
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):909-13. PubMed ID: 11429218
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH.
Bruheim K; Svartberg J; Carlsen E; Dueland S; Haug E; Skovlund E; Tveit KM; Guren MG
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):722-7. PubMed ID: 18262088
[TBL] [Abstract][Full Text] [Related]
11. Role of organ-sparing surgery in germ cell tumors of the testis.
Yossepowitch O; Baniel J
Urology; 2004 Mar; 63(3):421-7. PubMed ID: 15028430
[No Abstract] [Full Text] [Related]
12. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
13. Late hormonal levels, semen parameters, and presence of antisperm antibodies in patients treated for testicular torsion.
Arap MA; Vicentini FC; Cocuzza M; Hallak J; Athayde K; Lucon AM; Arap S; Srougi M
J Androl; 2007; 28(4):528-32. PubMed ID: 17287456
[TBL] [Abstract][Full Text] [Related]
14. Undetectable inhibin B serum levels in men after testicular irradiation.
Petersen PM; Andersson AM; Rørth M; Daugaard G; Skakkebaek NE
J Clin Endocrinol Metab; 1999 Jan; 84(1):213-5. PubMed ID: 9920086
[TBL] [Abstract][Full Text] [Related]
15. Impaired testicular function in patients with carcinoma-in-situ of the testis.
Petersen PM; Giwercman A; Hansen SW; Berthelsen JG; Daugaard G; Rørth M; Skakkebaek NE
J Clin Oncol; 1999 Jan; 17(1):173-9. PubMed ID: 10458231
[TBL] [Abstract][Full Text] [Related]
16. Treatment of testicular cancer: influence on pituitary-gonadal axis and sexual function.
Lackner J; Schatzl G; Koller A; Mazal P; Waldhoer T; Marberger M; Kratzik C
Urology; 2005 Aug; 66(2):402-6. PubMed ID: 16040104
[TBL] [Abstract][Full Text] [Related]
17. Gonadal function in patients with testicular germ cell tumors.
Tomomasa H; Oshio S; Ashizawa Y; Kamiyama Y; Okano Y; Iiyama T; Sato S; Shimizu H; Umeda T
Arch Androl; 2002; 48(6):405-15. PubMed ID: 12425758
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma in situ of the testis in the presence of contralateral germ cell tumor.
Kleinschmidt K; Kemper J; Holstein AF
Eur Urol; 1989; 16(1):74-7. PubMed ID: 2540984
[TBL] [Abstract][Full Text] [Related]
19. Effects of peppermint teas on plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels and testicular tissue in rats.
Akdogan M; Ozguner M; Kocak A; Oncu M; Cicek E
Urology; 2004 Aug; 64(2):394-8. PubMed ID: 15302514
[TBL] [Abstract][Full Text] [Related]
20. Endocrine function in patients treated for carcinoma in situ in the testis with irradiation.
Petersen PM; Daugaard G; Rørth M; Skakkebaek NE
APMIS; 2003 Jan; 111(1):93-8; discussion 98-9. PubMed ID: 12752244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]